24 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
15 May 24
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
8:30am
has played a key role in strengthening our operations network. During his tenure leading TGO, the organization has made tremendous strides serving
DEFA14A
TEVA
Teva- Pharmaceutical Industries Ltd.
24 May 23
Additional proxy soliciting materials
4:01pm
serving on our Board, the average tenure will be reduced to 6 years of service, and the average age of our directors will be reduced to 61.9 years.
Voting
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
21 Nov 22
Teva Announces Appointment of Richard Francis as President and CEO
7:00am
Exhibit 99.1
Teva Announces Appointment of Richard Francis as President and CEO
Kåre Schultz to Retire After a Transformative Five-Year Tenure … various leadership roles over a 13-year tenure at Biogen, including Senior Vice President of U.S. Commercial, Vice President / Senior Vice President
PRE 14A
swkiyue5my7b 4w1cm
19 Mar 20
Preliminary proxy
4:19pm
DEF 14A
62iam5er74hun4
25 Apr 18
Definitive proxy
12:00am
6-K
8i3veu91
18 Jun 14
Current report (foreign)
12:00am
6-K
EX-99.1
ot298k1
9 Jan 14
Teva Names Erez Vigodman as President and CEO
12:00am
6-K
f5vngri khwuh9e80vo3
18 Jul 13
Current report (foreign)
12:00am
6-K
EX-99.1
0x3k gphtv
29 Apr 13
Live Filing
12:00am
6-K
EX-99.1
mnl j8rgi88bc9m8gt8
3 Jan 12
Teva Announces Management Succession
12:00am